Stockscreener 앱 받기
6.47
1.97%
-0.13
전일 마감가:
$6.60
열려 있는:
$6.58
하루 거래량:
307.83K
Relative Volume:
1.13
시가총액:
$342.08M
수익:
$81.06M
순이익/손실:
$-55.55M
주가수익비율:
-5.6754
EPS:
-1.14
순현금흐름:
$-47.98M
1주 성능:
-9.89%
1개월 성능:
-22.88%
6개월 성능:
+84.33%
1년 성능:
+127.82%
1일 변동 폭
$6.41
$6.72
1주일 범위
$6.39
$7.545
52주 변동 폭
$2.03
$9.2362
Sight Sciences Inc Stock (SGHT) Company Profile
명칭
Sight Sciences Inc
전화
(415) 889-0550
주소
4040 CAMPBELL AVE,, MENLO PARK
SGHT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
6.47 | 348.95M | 81.06M | -55.55M | -47.98M | -1.14 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-05 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-08-08 | 업그레이드 | Lake Street | Hold → Buy |
| 2024-12-06 | 개시 | UBS | Buy |
| 2024-11-04 | 다운그레이드 | Lake Street | Buy → Hold |
| 2024-08-21 | 개시 | Lake Street | Buy |
| 2023-09-12 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-09-12 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-09-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-08-24 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-01-06 | 업그레이드 | Stifel | Hold → Buy |
| 2022-10-04 | 개시 | Needham | Hold |
| 2022-07-26 | 개시 | Stifel | Hold |
| 2022-02-03 | 개시 | William Blair | Outperform |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
모두보기
Sight Sciences Inc 주식(SGHT)의 최신 뉴스
Aug PostEarnings: Will Sight Sciences Inc benefit from sector rotationPortfolio Value Summary & Short-Term Trading Alerts - baoquankhu1.vn
Sight Sciences Releases Preliminary Q4 and 2025 Financial Results - VisionMonday.com
Sight Sciences (SGHT) Price Target Increased by 19.11% to 9.54 - Nasdaq
Sight Sciences reports Q4 revenue growth amid dry eye milestones By Investing.com - Investing.com Nigeria
Sight Sciences announces preliminary, unaudited fourth quarter and full year 2025 financial highlights - marketscreener.com
Sight Sciences Reports Preliminary Fourth Quarter and Full Year 2025 Financial Highlights - Quiver Quantitative
Eye care firm Sight Sciences reports 130% Dry Eye jump in late 2025 - Stock Titan
S P Trends: Will Sight Sciences Inc outperform tech stocks2025 Technical Overview & Technical Confirmation Alerts - baoquankhu1.vn
Sight Sciences (SGHT) – Analysts’ Recent Ratings Changes - Defense World
Looking At The Narrative For Sight Sciences SGHT After Medicare Coverage Shifts - Yahoo Finance
Sight Sciences, Inc. (NASDAQ:SGHT) Given Average Rating of "Hold" by Brokerages - MarketBeat
This Insider Has Just Sold Shares In Sight Sciences - Sahm
Will Sight Sciences Inc. stock maintain dividend yieldMarket Weekly Review & Weekly Top Gainers Trade List - Улправда
Sight Sciences, Inc.'s (NASDAQ:SGHT) largest shareholders are individual investors with 30% ownership, institutions own 25% - Yahoo Finance
Rodberg, Sight Sciences CFO, sells $38,890 in SGHT stock By Investing.com - Investing.com South Africa
Sight Sciences (SGHT) CTO Badawi sells $73k in stock By Investing.com - Investing.com Canada
Sight Sciences (SGHT): chief legal officer Hayden sells $86k in stock By Investing.com - Investing.com South Africa
Sight Sciences (SGHT) CTO Badawi sells $73k in stock - Investing.com
Sight Sciences (SGHT): chief legal officer Hayden sells $86k in stock - Investing.com
Insider Selling: Sight Sciences (NASDAQ:SGHT) CFO Sells 4,405 Shares of Stock - MarketBeat
What analysts say about Sight Sciences Inc stockDividend Aristocrats List & Affordable Trading Strategies - earlytimes.in
Piper Sandler upgrades Sight Sciences stock rating to Overweight By Investing.com - Investing.com Nigeria
Published on: 2026-01-06 08:42:12 - earlytimes.in
What drives Sight Sciences Inc stock priceTechnical Analysis Insights & Capital Growth Strategies - earlytimes.in
Piper Sandler upgrades Sight Sciences stock rating to Overweight - Investing.com
Piper Sandler upgrades Sight Sciences on strong business prospects - TradingView — Track All Markets
Sight sciences CTO David Badawi sells $15,081 in stock - MSN
The Truth About Sight Sciences Inc (SGHT): Silent Wall Street Underdog Or Total Flop? - AD HOC NEWS
Sight Sciences: Improving Medicare Coverage Drives Eye-Popping Price Surge (NASDAQ:SGHT) - Seeking Alpha
Sight Sciences (SGHT) price target increased by 22.34% to 8.01 - MSN
Institutions profited after Sight Sciences, Inc.'s (NASDAQ:SGHT) market cap rose US$48m last week but individual investors profited the most - simplywall.st
Sight Sciences price target raised to $12 from $7 at UBS - Yahoo Finance
UBS Maintains Sight Sciences (SGHT) Buy Recommendation - Nasdaq
SGHT’s price-to-cash ratio: Is it a good investment at the moment? - uspostnews.com
What makes Sight Sciences, Inc. (SGHT) a strong momentum stock: Buy now? - MSN
Sight Sciences (SGHT) Price Target Increased by 22.34% to 8.01 - Nasdaq
Will Sight Sciences Inc. stock benefit from sector rotationTrade Volume Summary & Low Drawdown Momentum Trade Ideas - Улправда
How resilient is Sight Sciences Inc. stock in market downturnsPortfolio Return Report & Reliable Entry Point Alerts - Улправда
Will Sight Sciences Inc. stock outperform Dow Jones index2025 Top Decliners & AI Based Buy/Sell Signal Reports - Улправда
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
Sight Sciences Earnings Notes - Trefis
Sight Sciences (SGHT) director and 10% owner buys 13,958 shares - Stock Titan
Exit Recap: Is Sight Sciences Inc. stock recession proofPortfolio Profit Report & Daily Chart Pattern Signals - Улправда
What Makes Sight Sciences, Inc. (SGHT) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Sight Sciences price target raised to $9.10 from $5.50 at Citi - MSN
Lake Street Remains a Buy on Sight Sciences (SGHT) - The Globe and Mail
Sight Sciences Inc (SGHT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
1.96%
자본화:
|
볼륨(24시간):